Abstract:Substance use disorders (SUDs) induce widespread molecular dysregulation in the nucleus accumbens (NAc), a brain region pivotal for coordinating motivation and reward. These molecular changes are thought to support lasting neural and behavioral disturbances that promote drug-seeking in addiction. However, different drug classes exert unique influences on neural circuits, cell types, physiology, and gene expression despite the overlapping symptomatology of SUDs. To better understand common and divergent molecular mechanisms governing SUD pathology, our goal was to survey cell-type-specific restructuring of the NAc transcriptional landscape in after psychostimulant or opioid exposure. We combined fluorescence-activated nuclei sorting and RNA sequencing to profile NAc D1 and D2 medium spiny neurons (MSNs) across cocaine and morphine exposure paradigms, including initial exposure, prolonged withdrawal after repeated exposure, and re-exposure post-withdrawal. Our analyses reveal that D1 MSNs display many convergent transcriptional responses across drug classes during exposure, whereas D2 MSNs manifest mostly divergent responses between cocaine and morphine, with morphine causing more adaptations in this cell type. Utilizing multiscale embedded gene co-expression network analysis (MEGENA), we discerned transcriptional regulatory networks subserving biological functions shared between cocaine and morphine. We observed largely integrative engagement of overlapping gene networks across drug classes in D1 MSNs, but opposite regulation of key D2 networks, highlighting potential therapeutic gene network targets within MSNs. These studies establish a landmark, cell-type-specific atlas of transcriptional regulation induced by cocaine and by morphine that can serve as a foundation for future studies towards mechanistic understanding of SUDs. Our findings, and future work leveraging this dataset, will pave the way for the development of targeted therapeutic interventions, addressing the urgent need for more effective treatments for cocaine use disorder and enhancing the existing strategies for opioid use disorder.

Molecular genetic probing of dopamine receptors in drug addiction.

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Locus-specific Epigenetic Remodeling Controls Addiction- and Depression-Related Behaviors

Gene Expression Profiling in Drug Addicted Brain

Genetics of Dopamine Receptors and Drug Addiction: a Comprehensive Review

Implication of Genes for the N -Methyl- d -Aspartate (NMDA) Receptor in Substance Addictions

Near-Infrared Fluorescent Nanoprobes for Revealing the Role of Dopamine in Drug Addiction

MicroRNAs in drug addiction: Current status and future perspectives

Positron Emission Tomography Molecular Imaging Of Dopaminergic System In Drug Addiction

Neuroproteomics and its applications in research on nicotine and other drugs of abuse.

T96GENETIC STUDY FOR SUBSTANCE DEPENDENCE AND ITS GENETIC CORRELATION WITH PSYCHIATRIC DISORDERS

Current Progresses in Drug Addiction Theories

Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction

Cocaine taking and craving produce distinct transcriptional profiles in dopamine neurons

Genes and (common) Pathways Underlying Drug Addiction

Circuit-wide Gene Network Analysis Reveals Sex-Specific Roles for Phosphodiesterase 1b in Cocaine Addiction

PROTEOMIC STUDY OF DRUG ADDICTION

The Analysis of Neuromolecular Mechanisms of Cocaine Dependence for Different Brain Areas and Differential-Term Access Based on Gene Expression Profiles

Cellular and Molecular Basis of Drug Addiction: the Role of Neuronal Ensembles in Addiction.

What Have We Learned (or Expect to) From Analysis of Murine Genetic Models Related to Substance Use Disorders?